URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Joseph Roscoe

Concepts (267)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Nausea
31
1998
153
8.360
Why?
Antineoplastic Agents
27
1998
598
4.330
Why?
Vomiting
17
1998
114
3.600
Why?
Neoplasms
30
1998
701
3.380
Why?
Antineoplastic Combined Chemotherapy Protocols
12
1986
409
2.760
Why?
Acupressure
5
2002
16
2.710
Why?
Fatigue
15
2001
122
2.440
Why?
Breast Neoplasms
19
1986
660
2.400
Why?
Antiemetics
12
1998
55
1.890
Why?
Vomiting, Anticipatory
7
1998
20
1.680
Why?
Acupuncture Therapy
4
2002
11
1.350
Why?
Sleep Disorders
4
2002
68
1.290
Why?
Middle Aged
44
1986
9461
1.140
Why?
Doxorubicin
7
2003
102
1.110
Why?
Aged
35
1989
6986
1.030
Why?
Radiotherapy
5
2002
179
1.010
Why?
Adult
35
1986
10906
0.940
Why?
Female
47
1986
19061
0.920
Why?
Humans
65
1986
35000
0.860
Why?
Depression
5
2001
419
0.830
Why?
Attitude
2
2000
63
0.800
Why?
Cisplatin
3
2000
93
0.760
Why?
Sleep
1
2011
56
0.750
Why?
Carboplatin
2
2003
29
0.700
Why?
Quality of Life
12
1998
486
0.690
Why?
Cerebral Cortex
1
2011
235
0.670
Why?
Cyclohexanecarboxylic Acids
3
2003
47
0.660
Why?
Amines
3
2003
64
0.660
Why?
Wrist
3
2002
49
0.660
Why?
gamma-Aminobutyric Acid
3
2003
90
0.640
Why?
Paroxetine
2
2003
11
0.610
Why?
Hot Flashes
2
2004
28
0.570
Why?
Fatigue Syndrome, Chronic
1
2007
11
0.560
Why?
Acetates
2
2003
64
0.550
Why?
Patient Education as Topic
6
2000
207
0.540
Why?
Serotonin Antagonists
4
1998
21
0.540
Why?
Psychophysiology
1
2006
15
0.530
Why?
Community Health Centers
2
2000
27
0.530
Why?
Aged, 80 and over
17
1989
2423
0.530
Why?
Male
31
1989
18870
0.530
Why?
Prochlorperazine
3
2005
11
0.510
Why?
Transcutaneous Electric Nerve Stimulation
1
2005
6
0.500
Why?
Treatment Outcome
14
1998
2487
0.500
Why?
Therapeutic Touch
1
2005
3
0.500
Why?
Antidepressive Agents, Second-Generation
1
2005
13
0.490
Why?
Behavior
1
2004
51
0.470
Why?
Selective Estrogen Receptor Modulators
1
2004
9
0.460
Why?
Physical Stimulation
1
2003
52
0.440
Why?
Tamoxifen
1
2004
80
0.440
Why?
Radiation Injuries
1
2005
123
0.440
Why?
Academic Medical Centers
2
2003
93
0.440
Why?
Double-Blind Method
7
2003
985
0.430
Why?
Behavior Therapy
4
1998
95
0.420
Why?
Electroacupuncture
1
2002
2
0.420
Why?
Benzhydryl Compounds
3
2005
13
0.380
Why?
Health Knowledge, Attitudes, Practice
3
2000
247
0.360
Why?
Outcome Assessment (Health Care)
1
2003
275
0.360
Why?
Severity of Illness Index
6
2000
878
0.320
Why?
Questionnaires
8
2000
942
0.320
Why?
Continental Population Groups
2
1997
116
0.310
Why?
Complementary Therapies
2
2006
37
0.310
Why?
Peritoneum
1
1997
14
0.300
Why?
Urea
1
1997
51
0.290
Why?
Kidney Failure, Chronic
2
1997
117
0.290
Why?
Peritoneal Dialysis
1
1997
18
0.290
Why?
Adaptation, Psychological
2
2006
202
0.290
Why?
Granisetron
2
1998
7
0.290
Why?
Perception
3
2004
60
0.270
Why?
Patient Satisfaction
3
2004
216
0.270
Why?
Risk Factors
3
2000
2172
0.240
Why?
Ondansetron
2
1998
10
0.230
Why?
Drug Administration Schedule
3
1989
362
0.230
Why?
Dexamethasone
2
2005
176
0.220
Why?
Age Factors
4
2004
1060
0.220
Why?
Activities of Daily Living
2
2001
250
0.220
Why?
Relaxation Therapy
2
2007
15
0.210
Why?
Pain
2
2006
363
0.210
Why?
Receptors, Neurokinin-1
1
2012
7
0.210
Why?
Quinuclidines
1
2012
6
0.210
Why?
Intention to Treat Analysis
1
2012
8
0.210
Why?
Morpholines
1
2012
38
0.210
Why?
Isoquinolines
1
2012
57
0.200
Why?
Professional Role
1
2012
21
0.200
Why?
Oral Health
1
2012
38
0.200
Why?
Polysomnography
1
2011
26
0.200
Why?
Ginger
1
2011
5
0.190
Why?
Mouth Diseases
1
2012
46
0.190
Why?
Phytotherapy
1
2011
17
0.190
Why?
Drug Therapy, Combination
1
2012
375
0.190
Why?
Psychology, Medical
1
2011
2
0.190
Why?
Cyclophosphamide
3
2003
169
0.190
Why?
Suggestion
1
2010
7
0.180
Why?
Benzodiazepines
1
2010
22
0.180
Why?
Self Efficacy
1
2011
44
0.180
Why?
Conditioning, Classical
1
2010
35
0.180
Why?
Receptors, Serotonin, 5-HT3
3
1998
8
0.180
Why?
Dentate Gyrus
1
2010
24
0.180
Why?
Central Nervous System Stimulants
1
2010
40
0.170
Why?
Clinical Trials as Topic
4
1989
664
0.170
Why?
Serotonin 5-HT3 Receptor Antagonists
2
2004
7
0.170
Why?
Pilot Projects
3
2004
426
0.170
Why?
Information Seeking Behavior
1
2009
3
0.170
Why?
Diabetes Mellitus, Type 2
1
2012
208
0.170
Why?
Community Health Services
2
2006
68
0.170
Why?
Hypnosis
2
2006
15
0.170
Why?
Adolescent
6
1989
4513
0.170
Why?
Information Services
1
2009
19
0.170
Why?
Blood-Brain Barrier
1
2010
103
0.170
Why?
Insulin-Like Growth Factor I
1
2010
98
0.170
Why?
Sleep Initiation and Maintenance Disorders
1
2009
45
0.160
Why?
Placebos
2
2005
177
0.160
Why?
Gene Expression Regulation, Neoplastic
1
2011
247
0.160
Why?
Awareness
1
2008
32
0.150
Why?
Pregnancy
2
2002
1919
0.150
Why?
Cognition Disorders
1
2011
262
0.150
Why?
Stress, Psychological
1
2011
264
0.150
Why?
Young Adult
2
2009
1013
0.150
Why?
Sickness Impact Profile
1
2007
35
0.150
Why?
Survivors
2
2004
112
0.140
Why?
Cognition
1
2009
216
0.140
Why?
Incidence
1
2009
644
0.140
Why?
Administration, Oral
2
2003
302
0.130
Why?
Placebo Effect
1
2006
36
0.130
Why?
Acupuncture Points
1
2005
2
0.130
Why?
Serotonin
2
2001
101
0.130
Why?
Choice Behavior
1
2006
44
0.130
Why?
Menopause
1
2005
40
0.130
Why?
Models, Psychological
1
2006
87
0.130
Why?
Sex Factors
3
1997
561
0.120
Why?
Motion Sickness
1
2004
8
0.120
Why?
Chronic Disease
1
2007
496
0.120
Why?
Exercise
1
2006
155
0.120
Why?
Tai Ji
1
2004
21
0.120
Why?
Analysis of Variance
4
2003
705
0.120
Why?
Decision Making
1
2006
220
0.110
Why?
Serotonin Uptake Inhibitors
1
2003
28
0.110
Why?
Combined Modality Therapy
1
2005
459
0.110
Why?
Demography
3
2006
95
0.110
Why?
Receptors, Serotonin
2
1998
11
0.110
Why?
Pregnancy Complications
1
2004
194
0.100
Why?
New England
1
2002
22
0.100
Why?
Cross-Over Studies
1
2002
117
0.100
Why?
Peritoneal Dialysis, Continuous Ambulatory
1
2001
6
0.100
Why?
Health Surveys
3
2004
198
0.100
Why?
Affect
1
2001
73
0.100
Why?
Patients
1
2001
43
0.090
Why?
Circadian Rhythm
1
2001
80
0.090
Why?
Reference Values
1
2002
427
0.090
Why?
Time Factors
5
1986
3047
0.090
Why?
Multivariate Analysis
1
2002
487
0.090
Why?
Ovarian Neoplasms
1
2000
105
0.080
Why?
Self-Assessment
2
2006
51
0.080
Why?
Follow-Up Studies
4
1989
1757
0.080
Why?
Regression Analysis
1
2000
489
0.080
Why?
Diabetic Nephropathies
1
1997
23
0.070
Why?
Patient Acceptance of Health Care
2
2008
100
0.070
Why?
Permeability
1
1997
79
0.070
Why?
Carcinoma
1
1999
188
0.070
Why?
Asian Continental Ancestry Group
1
1997
29
0.070
Why?
Weight Loss
2
2004
63
0.070
Why?
Animals
2
2010
15647
0.070
Why?
African Continental Ancestry Group
1
1997
116
0.070
Why?
Biological Transport
1
1997
364
0.070
Why?
Prostatic Neoplasms
1
2002
548
0.070
Why?
Ethnic Groups
1
1997
137
0.070
Why?
Physician-Patient Relations
3
2000
333
0.070
Why?
Palliative Care
1
1998
151
0.070
Why?
Social Support
2
2004
214
0.070
Why?
United States
3
2006
2511
0.070
Why?
Longitudinal Studies
2
2005
372
0.070
Why?
European Continental Ancestry Group
1
1997
225
0.060
Why?
Attitude to Health
2
2006
198
0.060
Why?
Prevalence
2
2002
530
0.060
Why?
Dose-Response Relationship, Drug
2
2001
1085
0.060
Why?
New York
2
2006
1191
0.050
Why?
General Practice
1
2012
1
0.050
Why?
Directive Counseling
1
2012
4
0.050
Why?
Patient Preference
1
2012
9
0.050
Why?
Dentistry
1
2012
19
0.050
Why?
Qualitative Research
1
2012
54
0.050
Why?
Self Care
1
2012
60
0.050
Why?
Interviews as Topic
1
2012
157
0.050
Why?
Indiana
1
2011
6
0.050
Why?
Massage
1
2011
9
0.050
Why?
Factor Analysis, Statistical
1
2011
56
0.050
Why?
Interleukin-8
1
2011
108
0.040
Why?
Patient Care Team
1
2012
189
0.040
Why?
Energy Metabolism
1
2011
132
0.040
Why?
Bromodeoxyuridine
1
2010
63
0.040
Why?
Chemokine CCL2
1
2011
124
0.040
Why?
Neurogenesis
1
2010
25
0.040
Why?
Fluorouracil
1
2010
77
0.040
Why?
Paclitaxel
1
2010
56
0.040
Why?
Psychometrics
1
2011
212
0.040
Why?
Outpatients
1
2009
29
0.040
Why?
Glomerulonephritis, Membranous
1
1989
2
0.040
Why?
Confidence Intervals
1
2009
155
0.040
Why?
Interleukin-6
1
2011
314
0.040
Why?
Memory
1
2009
95
0.040
Why?
Health Behavior
1
2009
97
0.040
Why?
Needs Assessment
1
2009
87
0.040
Why?
Health Services Needs and Demand
1
2009
93
0.040
Why?
Prednisone
1
1989
178
0.040
Why?
Odds Ratio
1
2009
301
0.040
Why?
National Cancer Institute (U.S.)
1
2007
11
0.040
Why?
Attention
1
2009
145
0.040
Why?
Reproducibility of Results
1
2011
859
0.040
Why?
Quality Indicators, Health Care
1
2007
54
0.040
Why?
Cell Proliferation
1
2010
480
0.030
Why?
Cognitive Therapy
1
2007
39
0.030
Why?
Sulfinpyrazone
1
1986
2
0.030
Why?
Argininosuccinic Acid
1
1986
3
0.030
Why?
Mitomycins
1
1986
17
0.030
Why?
Plasmapheresis
1
1986
25
0.030
Why?
National Institutes of Health (U.S.)
1
2006
60
0.030
Why?
Cancer Care Facilities
1
2006
10
0.030
Why?
Arginine
1
1986
107
0.030
Why?
Program Evaluation
1
2006
170
0.030
Why?
Chemotherapy, Adjuvant
1
2006
85
0.030
Why?
Radiotherapy, Adjuvant
1
2006
72
0.030
Why?
Electric Stimulation Therapy
1
2005
29
0.030
Why?
Radiation Dosage
1
2005
115
0.030
Why?
Mice, Inbred C57BL
1
2010
1613
0.030
Why?
Alopecia
1
2004
22
0.030
Why?
Antidepressive Agents
1
2005
88
0.030
Why?
Psychotherapy
1
2005
82
0.030
Why?
Acute Disease
1
2005
570
0.030
Why?
Self Concept
1
2004
102
0.030
Why?
Blood Platelets
1
1986
271
0.030
Why?
Educational Status
1
2004
172
0.030
Why?
Glucocorticoids
1
2005
159
0.030
Why?
Communication
1
2006
245
0.030
Why?
Randomized Controlled Trials as Topic
1
2005
400
0.030
Why?
Psychiatric Status Rating Scales
1
2003
306
0.030
Why?
Chi-Square Distribution
1
2003
320
0.030
Why?
Neurons
1
2010
1053
0.030
Why?
Hospitals, Chronic Disease
1
2001
2
0.020
Why?
Ontario
1
2001
10
0.020
Why?
Behavioral Medicine
1
2001
10
0.020
Why?
Peritonitis
1
2001
33
0.020
Why?
Health Status Indicators
1
2002
97
0.020
Why?
Infection
1
2001
66
0.020
Why?
Pituitary-Adrenal System
1
2001
31
0.020
Why?
Vagus Nerve
1
2001
39
0.020
Why?
Autonomic Nervous System
1
2001
69
0.020
Why?
Hypothalamo-Hypophyseal System
1
2001
50
0.020
Why?
Catheters, Indwelling
1
2001
69
0.020
Why?
Anemia
1
2001
76
0.020
Why?
Sampling Studies
1
2000
47
0.020
Why?
Professional-Patient Relations
1
2000
41
0.020
Why?
Breast Neoplasms, Male
1
1999
6
0.020
Why?
Informed Consent
1
2000
77
0.020
Why?
Adenosine Triphosphate
1
2001
394
0.020
Why?
Mice
1
2010
5900
0.020
Why?
Data Collection
1
2000
201
0.020
Why?
Emetics
1
1998
4
0.020
Why?
Cytokines
1
2001
555
0.020
Why?
Creatinine
2
1986
128
0.020
Why?
Sensitivity and Specificity
1
2000
866
0.020
Why?
Retrospective Studies
1
2001
2167
0.020
Why?
Proteinuria
1
1989
29
0.010
Why?
Random Allocation
1
1989
245
0.010
Why?
Tablets, Enteric-Coated
1
1986
2
0.010
Why?
Dipyridamole
1
1986
9
0.010
Why?
Mitomycin
1
1986
18
0.010
Why?
Prospective Studies
1
1989
1606
0.010
Why?
Adenocarcinoma
1
1986
431
0.010
Why?

Visualizations


Roscoe's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department